Artiva

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Motley Fool
Thu, 08/29/24 - 11:10 am
IPOs
Artiva
autoimmune diseases
cell therapy
AlloNK
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Dive
Fri, 07/19/24 - 11:43 am
Artiva
IPOs
autoimmune disease
Artiva sets out $135M IPO plans to push NK cell therapy through trials
Fierce Biotech
Mon, 07/15/24 - 09:58 am
Artiva
IPO
autoimmune disease
natural killer cell therapies
Artiva, fresh from Merck pact, raises $120M for NK therapy R&D
Fierce Biotech
Mon, 03/1/21 - 10:39 am
Artiva
natural killer cell therapy
Merck
R&D
Natural killer biotech Artiva launches with $78M, industry veterans
Fierce Biotech
Fri, 06/26/20 - 09:50 am
immuno-oncology
natural killer cell therapy
Artiva